JP2005525398A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005525398A5 JP2005525398A5 JP2003584046A JP2003584046A JP2005525398A5 JP 2005525398 A5 JP2005525398 A5 JP 2005525398A5 JP 2003584046 A JP2003584046 A JP 2003584046A JP 2003584046 A JP2003584046 A JP 2003584046A JP 2005525398 A5 JP2005525398 A5 JP 2005525398A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- aryl
- group
- alkoxy
- atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 125000000217 alkyl group Chemical group 0.000 claims 217
- 125000003118 aryl group Chemical group 0.000 claims 85
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 58
- 125000003545 alkoxy group Chemical group 0.000 claims 38
- 125000002950 monocyclic group Chemical group 0.000 claims 30
- 229910052760 oxygen Inorganic materials 0.000 claims 30
- 229910052717 sulfur Inorganic materials 0.000 claims 30
- 150000001875 compounds Chemical class 0.000 claims 29
- 125000004430 oxygen atom Chemical group O* 0.000 claims 29
- 125000004434 sulfur atom Chemical group 0.000 claims 29
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 26
- 208000035475 disorder Diseases 0.000 claims 26
- 125000002877 alkyl aryl group Chemical group 0.000 claims 23
- 229910052736 halogen Inorganic materials 0.000 claims 22
- 150000002367 halogens Chemical group 0.000 claims 22
- 125000004093 cyano group Chemical group *C#N 0.000 claims 19
- 125000003342 alkenyl group Chemical group 0.000 claims 16
- 229910052739 hydrogen Inorganic materials 0.000 claims 16
- 239000001257 hydrogen Substances 0.000 claims 16
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 16
- 125000001424 substituent group Chemical group 0.000 claims 14
- 102000010183 Bradykinin receptor Human genes 0.000 claims 13
- 108050001736 Bradykinin receptor Proteins 0.000 claims 13
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 13
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 12
- 125000000623 heterocyclic group Chemical group 0.000 claims 12
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 12
- 229910052799 carbon Inorganic materials 0.000 claims 11
- 229920006395 saturated elastomer Polymers 0.000 claims 10
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical group C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 claims 8
- 125000004414 alkyl thio group Chemical group 0.000 claims 8
- 125000000304 alkynyl group Chemical group 0.000 claims 8
- 125000004104 aryloxy group Chemical group 0.000 claims 8
- 125000004001 thioalkyl group Chemical group 0.000 claims 8
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 7
- 230000001225 therapeutic effect Effects 0.000 claims 7
- 125000001072 heteroaryl group Chemical group 0.000 claims 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 6
- 238000009472 formulation Methods 0.000 claims 5
- 238000004519 manufacturing process Methods 0.000 claims 5
- -1 methylenedioxy Chemical group 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 5
- 125000005551 pyridylene group Chemical group 0.000 claims 4
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 claims 3
- 125000004450 alkenylene group Chemical group 0.000 claims 2
- 125000003282 alkyl amino group Chemical group 0.000 claims 2
- 125000002947 alkylene group Chemical group 0.000 claims 2
- 125000004429 atom Chemical group 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims 2
- 125000003386 piperidinyl group Chemical group 0.000 claims 2
- 125000004076 pyridyl group Chemical group 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 125000005556 thienylene group Chemical group 0.000 claims 2
- 125000005001 aminoaryl group Chemical group 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37135002P | 2002-04-10 | 2002-04-10 | |
| PCT/US2003/009974 WO2003087090A2 (en) | 2002-04-10 | 2003-03-31 | Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005525398A JP2005525398A (ja) | 2005-08-25 |
| JP2005525398A5 true JP2005525398A5 (enExample) | 2006-05-25 |
Family
ID=29250669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003584046A Withdrawn JP2005525398A (ja) | 2002-04-10 | 2003-03-31 | ブラジキニン受容体モジュレーターとして有用な新規なヘテロアリールアルキルアミド誘導体 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US6958349B2 (enExample) |
| EP (1) | EP1495017A2 (enExample) |
| JP (1) | JP2005525398A (enExample) |
| AU (1) | AU2003226188A1 (enExample) |
| CA (1) | CA2481855A1 (enExample) |
| WO (1) | WO2003087090A2 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2509881A1 (en) * | 2002-12-19 | 2004-07-08 | Elan Pharmaceuticals, Inc. | Substituted n-phenyl sulfonamide bradykinin antagonists |
| SG182849A1 (en) | 2003-04-25 | 2012-08-30 | Gilead Sciences Inc | Antiviral phosphonate analogs |
| PT2258376T (pt) | 2004-07-27 | 2019-05-31 | Gilead Sciences Inc | Análogos fosfonatados de compostos inibidores do vih |
| WO2008026018A1 (en) * | 2006-09-01 | 2008-03-06 | Topotarget Switzerland Sa | New method for the treatment of inflammatory diseases |
| TWI407960B (zh) | 2007-03-23 | 2013-09-11 | Jerini Ag | 小分子緩激肽ｂ２受體調節劑 |
| US7807629B1 (en) | 2007-06-05 | 2010-10-05 | Alcon Research, Ltd. | Use of bradykinin and related B2R agonists to treat ocular hypertension and glaucoma |
| US8173668B1 (en) | 2007-06-05 | 2012-05-08 | Alcon Research, Ltd. | Use of non-peptidic bradykinin receptor agonists to treat ocular hypertension and glaucoma |
| BRPI0915878A2 (pt) | 2008-07-08 | 2015-11-03 | Gilead Sciences Inc | sais ou hidratos de compostos inibidores de hiv, seu uso e composição farmacêutica que os compreende |
| EP2830643A1 (en) | 2012-03-26 | 2015-02-04 | INSERM - Institut National de la Santé et de la Recherche Médicale | Methods and pharmaceutical compositions for prevention or treatment of ischemia related organ damage |
| KR20150127718A (ko) * | 2013-03-14 | 2015-11-17 | 샤이어 휴먼 지네틱 테라피즈 인크. | Ｂ2-브라디키닌 수용체 매개 혈관부종의 치료 방법 |
| BR112016030787B1 (pt) * | 2014-07-01 | 2022-12-20 | Takeda Pharmaceutical Company Limited | Entidade química, composição farmacêutica e seu uso |
| PT3661937T (pt) | 2017-08-01 | 2021-09-24 | Gilead Sciences Inc | Formas cristalinas de ((s)-((((2r,5r)-5-(6-amino-9h-purin-9-il)-4-fluoro-2,5-dihidrofurano-2-il)oxi)metil)(fenoxi)fosforil)-l-alaninato de etil (gs-9131) para tratamento de infeções virais |
| SMT202200154T1 (it) | 2017-11-24 | 2022-05-12 | Pharvaris Netherlands B V | Nuovi antagonisti del recettore della bradichinina b2 |
| AR118983A1 (es) | 2019-05-23 | 2021-11-17 | Pharvaris Gmbh | Antagonistas cíclicos del receptor b2 de bradiquinina |
| UY38706A (es) | 2019-05-23 | 2020-12-31 | Pharvaris Gmbh | Antagonistas cíclicos del receptor b2 de bradiquinina |
| TW202345810A (zh) | 2022-03-25 | 2023-12-01 | 瑞士商帕法瑞斯有限責任公司 | 包含緩激肽ｂ２受體拮抗劑之固態延長釋放組成物 |
| WO2023180577A1 (en) | 2022-03-25 | 2023-09-28 | Pharvaris Gmbh | Therapeutic uses of bradykinin b2-receptor antagonists |
| HRP20260166T1 (hr) | 2022-03-25 | 2026-03-27 | Pharvaris Gmbh | Čvrsti sastav koji sadrži solubilizirane antagoniste bradikinin b2 receptora |
| CN117342963B (zh) * | 2023-09-28 | 2025-06-17 | 上海予君生物科技发展有限公司 | 一种1,4-二羰基化合物、及其制备方法和应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5574042A (en) * | 1992-11-02 | 1996-11-12 | Fujisawa Pharmaceutical Co., Ltd | Imidazo [1,2-a] pyridines and their pharmaceutical use |
| AU686115B2 (en) * | 1992-11-02 | 1998-02-05 | Fujisawa Pharmaceutical Co., Ltd. | Imidazo (I,2-a) pyridine derivatives as bradykinin antagonists, pharmaceuticals and processes for their preparation |
| AU680870B2 (en) * | 1993-04-28 | 1997-08-14 | Astellas Pharma Inc. | New heterocyclic compounds |
| GB9519077D0 (en) * | 1995-09-18 | 1995-11-15 | Fujisawa Pharmaceutical Co | New heterocyclic compounds |
| DE19610784A1 (de) | 1996-03-19 | 1997-09-25 | Hoechst Ag | Fluoralkyl- und Fluoralkoxysubstituierte heterocyclische Bradykinin-Antagonisten, Verfahren zu ihrer Herstellung und ihre Verwendung |
| DE19712960A1 (de) * | 1997-03-27 | 1998-10-01 | Hoechst Ag | Benzyloxy-substituierte, anellierte N-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Bradykininrezeptorantagonisten |
| AU1146099A (en) * | 1997-09-18 | 1999-04-05 | Janssen Pharmaceutica N.V. | Fused imidazole derivatives for improving oral bioavailability of pharmaceuticalagents |
| WO1999051235A1 (en) * | 1998-04-03 | 1999-10-14 | Alcon Laboratories, Inc. | Non-peptide bradykinin receptor antagonists for use in controlling intraocular pressure and treating glaucoma |
| EP1123288A1 (en) * | 1998-10-21 | 2001-08-16 | Fujisawa Pharmaceutical Co., Ltd. | Vitreous form of known bradykinin antagonist |
-
2003
- 2003-03-31 JP JP2003584046A patent/JP2005525398A/ja not_active Withdrawn
- 2003-03-31 EP EP03746573A patent/EP1495017A2/en not_active Withdrawn
- 2003-03-31 WO PCT/US2003/009974 patent/WO2003087090A2/en not_active Ceased
- 2003-03-31 AU AU2003226188A patent/AU2003226188A1/en not_active Abandoned
- 2003-03-31 US US10/403,186 patent/US6958349B2/en not_active Expired - Lifetime
- 2003-03-31 CA CA002481855A patent/CA2481855A1/en not_active Abandoned
-
2004
- 2004-12-16 US US11/014,471 patent/US7358261B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2388750C2 (ru) | Ингибиторы фосфодиэстеразы 4, включая аналоги n-замещенного диариламина | |
| JP2005537323A5 (enExample) | ||
| RU2403247C2 (ru) | Модуляторы никотиновых ацетилхолиновых рецепторов альфа 7 и их терапевтические применения | |
| JP2010510999A5 (enExample) | ||
| AR061584A1 (es) | Uso de 2-aminotetralinas sustituidas para la fabricacion de un medicamento para la prevencion, alivio y/o tratamiento de diversos tipos de dolor | |
| RU2219179C2 (ru) | Азациклические соединения, фармацевтические композиции | |
| JP2004503501A5 (enExample) | ||
| RU96104356A (ru) | Производные амидина, обладающие активностью против синтетазы оксида азота (у) | |
| JP2006524222A5 (enExample) | ||
| RU2005109913A (ru) | Азабициклоалкильные эфиры и их применение в качестве агонистов альфа7-nachr | |
| FI3518960T3 (fi) | Annostusohjelma kontrolloidusti vapautuvalle PTH-yhdisteelle | |
| JP2013509392A5 (enExample) | ||
| JP2007507494A5 (enExample) | ||
| EP2131828A2 (en) | Ampa and nmda receptor antagonists for neurodegenerative diseases | |
| RU2001107139A (ru) | Мускариновые агонисты и антагонисты | |
| JP2005538111A5 (enExample) | ||
| JP2005505583A5 (enExample) | ||
| JP2019526546A5 (enExample) | ||
| RU2002133458A (ru) | Соединения пиперазина и пиперидина | |
| RU2004139122A (ru) | Производные n-бензоилуреидокоричной кислоты, способ их получения и их применение | |
| RU2003131970A (ru) | Производные 4-(фенил-пиперидин-4-илиден-метил)-бензамида и их применение для лечения боли, тревоги или желудочно-кишечных расстройств | |
| JP2002526530A5 (enExample) | ||
| JP2003513066A5 (enExample) | ||
| JP2002529497A5 (enExample) | ||
| RU2007125130A (ru) | Применение атазанавира для улучшения фармакокинетики лекарственных средств, метаболизируемых ugt1a1 |